What is TSM naltrexone?
TSM (The Sinclair Method) is a clinician-supervised naltrexone approach that pairs medication with drinking occasions so alcohol's reward loop may weaken over time. This article explains how it differs from daily naltrexone, why moderation can be part of the conversation, and which safety questions belong with a licensed prescriber.
Most alcohol treatment starts with the same instruction: stop drinking first, then we will help you stay stopped. The Sinclair Method asks for the opposite. You take a pill, then you go drink — on purpose, at the times you would have been drinking anyway. That reversal is the whole idea, and it is also why the approach confuses people. So it is worth walking through what is actually happening in the brain when someone drinks on this medication, and why the timing is the point.
The idea: teaching the brain to lose interest
TSM is shorthand for The Sinclair Method, named for David Sinclair, a neuroscientist who spent decades studying why drinking reinforces itself. The medication at the center of it is naltrexone, and to understand the method you first have to understand what the drug does on any given night.
Alcohol gives most people a small pleasant lift, and a lot of that lift runs through the brain's endorphin system — the same feel-good chemistry that opioids act on. Naltrexone sits on those endorphin receptors and blocks them. The American Academy of Family Physicians explains it plainly: opioid receptors appear to carry a lot of alcohol's pleasant effect, so a drug that blocks those receptors turns that effect down. SAMHSA describes naltrexone the same way — it binds to endorphin receptors and blunts the effects and feelings of alcohol, and over time it lowers cravings and how much people drink.
Here is where Sinclair's specific insight comes in. If you drink while that reward is chemically muted, the drink no longer delivers the payoff your brain learned to expect. Do that again and again, and the learned link between "drink" and "reward" starts to fade. Sinclair called this pharmacological extinction — the drinking behavior slowly goes quiet because it stops being reinforced. In his review of the approach, Sinclair was explicit that the mechanism only works if the alcohol and the active medication are in the body at the same time. The drinking has to happen with the block in place. That is not a loophole in the method; it is the engine of it.
That mechanism is also why TSM gets talked about as a harm-reduction path rather than an abstinence-first one. You are not white-knuckling a craving or swearing off alcohol on day one. You keep drinking, at least at first, while the pull of it is gradually weakened — which is a very different starting point from "quit, then hold the line."
How it differs from taking naltrexone every day
Same molecule, same receptors — but two different ways to use it, built on two different goals.
The standard approach in most U.S. guidance is a steady daily dose. The logic is coverage: if the medication is always in your system, then it is already working on any night you happen to drink, planned or not, and it can blunt cravings even on days you do not drink at all. That pairs naturally with an abstinence goal — the aim is not drinking, and the medicine helps quiet the wanting.
TSM uses the timing differently. The medication is taken ahead of a drinking occasion so that it is active precisely when alcohol shows up, and the goal is not steady coverage but that extinction effect — repeated drinking sessions with the reward blocked, so the habit itself loses its grip. An early study by Heinälä and colleagues tested exactly this targeted, drink-linked use rather than a fixed daily habit. The practical trade is real: daily dosing is one less thing to plan, while targeted dosing asks you to connect the medication to the drinking every single time — and skipping it on a drinking day works against the whole mechanism.
Neither is a universally "right" way to use the drug, because they are built for different goals. Someone set on full abstinence and someone hoping to cut back are not actually asking the same question, and the daily-versus-targeted choice tends to follow from that. It is one of the more useful things to sort out with a prescriber before starting, rather than after.
Does the timing actually change the outcome?
This is the obvious next question, and it deserves a straight answer rather than a sales pitch. The honest version is that the targeted, drink-linked schedule has genuine research behind it — Sinclair's extinction model and the Heinälä trial are real work, not marketing — but the broad evidence base that regulators and reviewers lean on studied naltrexone mostly as part of a supervised treatment plan, without singling out one dosing schedule as the winner.
What the strongest evidence supports is naltrexone itself, not a particular clock. The Agency for Healthcare Research and Quality's comparative review places oral naltrexone among the best-supported medications for reducing a return to drinking. It does not crown targeted timing over daily dosing; that finer comparison is exactly the kind of individual question the evidence leaves to a clinician and the person in front of them. So if you have read that TSM is "more effective," treat that as a claim to explore with a prescriber, not a settled fact — the medication is well-supported; the best schedule for you is the open part.
The safety line that is not optional
One caution sits above all the others and is not a matter of preference. Naltrexone blocks opioid receptors, which is the point for alcohol — but it means the drug is genuinely dangerous for anyone using opioids. The FDA label lists it as contraindicated for people taking opioid pain medication, dependent on opioids, or in opioid withdrawal, because starting naltrexone in that situation can force a sudden, severe withdrawal. If you use opioids for pain, or have recently used heroin, fentanyl, or prescription opioids, that is not a detail to leave out — it is the single most important thing a prescriber needs to know. The same label also notes that naltrexone is meant to work as part of a broader treatment plan, not as a standalone fix.
It is also worth being clear about what TSM is not. It is not disulfiram (Antabuse), which works as a tripwire — it makes you physically ill if you drink. Naltrexone does not do that. You can drink on it; the point is that the drink simply does less for you. Two very different tools with two very different logics.
What to do with this
A few concrete handles, depending on where you are starting:
- Name the goal before the method. Cut back, or stop entirely? TSM is often discussed for the former, daily dosing for the latter, and being honest about which one you actually want lets a clinician match the approach to you instead of the reverse.
- If you want to try it, do it with a prescriber, not a forum. Online groups can make the approach feel less isolating, but timing, interactions, liver questions, and the opioid caution are medical decisions. Peer stories are context, not a protocol.
- Track the pattern, not one night. Notes on how often you drink, how strong the cravings are, and any side effects give a follow-up visit something real to work from — change usually shows up across weeks, not in a single evening.
To put the interest in perspective: in 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder — about 9.7% of that age group, according to NIAAA.
The gap between that number and actual care is its own fact. NIAAA's treatment data show that in 2024 only about 2.1 million of those people — roughly 7.6% — received any alcohol-use treatment at all, medication or otherwise. That is less a verdict on the medicines than a sign of how rarely the conversation happens in the first place.
If you have decided TSM is worth a real medical conversation and do not already have someone to raise it with, Clero connects you with a licensed clinician by telehealth to review your history and whether a medication approach like naltrexone fits — the article can frame the question, but only a clinician can answer it for you.
This is general education, not medical advice, a dosing guide, or a prescription. Decisions about naltrexone belong with a licensed clinician who knows your history; if drinking or thoughts of self-harm ever leave you feeling unsafe, call or text 988, and if cutting back brings on shaking, confusion, hallucinations, or a seizure, treat it as an emergency and call 911 or go to an emergency room.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.
